Flotek Industries (FTK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Special meeting scheduled for July 9, 2025, to vote on two key items: approval of common stock issuance underlying the April 2025 Warrant held by ProFrac GDM, LLC, and potential adjournment to solicit additional proxies if needed.
The Board unanimously recommends voting in favor of both proposals.
Proxy materials are available online, and shareholders are encouraged to vote electronically, by phone, or by mail.
Voting matters and shareholder proposals
Item 1 seeks approval for issuing up to 6 million shares of common stock upon exercise of the April 2025 Warrant, issued as part of an asset purchase and leaseback transaction with ProFrac GDM, LLC.
Item 2 authorizes adjournment of the meeting to solicit additional proxies if there are insufficient votes for Item 1.
Both items require a majority of shares present and entitled to vote for approval; abstentions count as votes against.
Voting agreements are in place with directors, executive officers, and ProFrac affiliates, representing about 53.5% of voting power as of the record date.
Board of directors and corporate governance
A special committee of disinterested and independent directors was formed to review and approve the transaction with ProFrac, excluding conflicted directors.
The committee engaged independent legal and financial advisors and received a fairness opinion before recommending the transaction.
ProFrac Holdings has the right to designate up to four board members, with independence requirements for most designees.
Latest events from Flotek Industries
- Record 2025 growth led by Data Analytics, Chemistry, and high-margin recurring revenue contracts.FTK
Q4 202512 Mar 2026 - Turnaround yields EBITDA growth, data analytics expansion, and rising market share in completions.FTK
2024 Annual Gateway Conference3 Feb 2026 - Q2 2024 net income rose to $2.0M as revenue grew sequentially and new EPA markets opened.FTK
Q2 20242 Feb 2026 - Q3 2024 saw higher revenue, profits, and guidance, with Data Analytics and Chemistry driving growth.FTK
Q3 202416 Jan 2026 - Sustained EBITDA growth and innovation drive profitability and market share gains.FTK
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Record 2024 results with robust growth, margin expansion, and strong outlook for 2025.FTK
Q4 202424 Dec 2025 - Shelf registration enables up to $200M in offerings; ProFrac holds major board influence.FTK
Registration Filing16 Dec 2025 - $105M asset acquisition and leaseback expands data analytics, driving growth and shareholder value.FTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, pay, auditor, and plan amendments, with strong governance focus.FTK
Proxy Filing1 Dec 2025